Publications by authors named "K Kaminska"

The AGBL5 gene encodes for the Cytoplasmic Carboxypeptidase 5 (CCP5), an α-tubulin deglutamylase that cleaves the γ-carboxyl-linked branching point of glutamylated tubulin. To date, pathogenic variants in AGBL5 have been associated only with isolated retinitis pigmentosa (RP). Hearing loss has not been reported in AGBL5-caused retinal disease.

View Article and Find Full Text PDF

Here we conduct a study involving 12 individuals with retinal dystrophy, neurological impairment, and skeletal abnormalities, with special focus on GPATCH11, a lesser-known G-patch domain-containing protein, regulator of RNA metabolism. To elucidate its role, we study fibroblasts from unaffected individuals and patients carrying the recurring c.328+1 G > T mutation, which specifically removes the main part of the G-patch domain while preserving the other domains.

View Article and Find Full Text PDF
Article Synopsis
  • The renin-angiotensin-aldosterone system (RAAS) is essential for regulating cardiovascular health and is a target for various therapeutic drugs, especially in managing diseases like hypertension and heart failure.
  • Dysregulation of RAAS has drawn attention in cancer treatment due to its impact on tumor biology and cardiovascular toxicities from oncological therapies.
  • RAAS inhibitors (RAASi) could serve as supportive treatments that help mitigate cardiovascular risks and improve outcomes in cancer patients undergoing therapies that can lead to cardiovascular complications.
View Article and Find Full Text PDF

Purpose: To measure the retinal oxygen metabolic function with retinal oximetry (RO) in patients with choroideremia (CHM) and compare these findings with retinitis pigmentosa (RP) patients and controls.

Methods: Prospective observational study including 18 eyes of 9 molecularly confirmed CHM patients (9♂; 40.2 ± 21.

View Article and Find Full Text PDF

The use of phosphodiesterase inhibitors in the treatment of Parkinson's disease is currently widely discussed. The study aimed to investigate the impact of acute and chronic treatment with the phosphodiesterase 5 inhibitor, sildenafil, at low and moderate doses of 2 mg/kg and 6 mg/kg, and L-DOPA (12.5 mg/kg), alone or in combination, on asymmetric behavior and dopamine (DA) and serotonin metabolism in the striatum and substantia nigra of unilaterally 6-OHDA-lesioned rats.

View Article and Find Full Text PDF